| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/11/2002 | CA2425712A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/11/2002 | CA2425169A1 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424952A1 Listeria inocua, genome and applications |
| 04/11/2002 | CA2424936A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
| 04/11/2002 | CA2424892A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 04/11/2002 | CA2424863A1 Vaccine composition and stabilisation method |
| 04/11/2002 | CA2424836A1 Pharmaceutical composition for immunisation against aids |
| 04/11/2002 | CA2424834A1 Nogo receptor homologs |
| 04/11/2002 | CA2424749A1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | CA2424623A1 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| 04/11/2002 | CA2424545A1 Chlamydia pmp proteins, gene sequences and uses thereof |
| 04/11/2002 | CA2424543A1 Component for vaccine |
| 04/11/2002 | CA2424296A1 Human anti-cd40 antibodies |
| 04/11/2002 | CA2424275A1 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423656A1 Methods and compositions for enhancing angiogenesis |
| 04/11/2002 | CA2423610A1 Split enveloped virus preparation |
| 04/11/2002 | CA2423436A1 Methods and compositions for modulating t cell activation and uses thereof |
| 04/11/2002 | CA2423307A1 Stabilisation of plasmid inheritance in bacteria |
| 04/11/2002 | CA2422642A1 Human prostate specific g-protein receptor hpraj70 |
| 04/10/2002 | EP1195438A1 Genetic immunisation against cervical carcinoma |
| 04/10/2002 | EP1195381A1 Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes |
| 04/10/2002 | EP1195162A1 Vaccine preparations containing fatty acids as constituent |
| 04/10/2002 | EP1195161A2 Anti-IgE vaccines |
| 04/10/2002 | EP1194581A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 04/10/2002 | EP1194580A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 04/10/2002 | EP1194576A1 Delivery system |
| 04/10/2002 | EP1194571A1 Prostase vaccine |
| 04/10/2002 | EP1194568A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 04/10/2002 | EP1194563A1 Fimh adhesin-based vaccines |
| 04/10/2002 | EP1194561A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 04/10/2002 | EP1194560A2 Antigenic neisserial peptides |
| 04/10/2002 | EP1194559A1 Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
| 04/10/2002 | EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 04/10/2002 | EP1194546A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 04/10/2002 | EP1194545A2 Secreted polypeptides and corresponding polynucleotides |
| 04/10/2002 | EP1194528A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/10/2002 | EP1194451A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 04/10/2002 | EP1194450A1 Inactivated vaccine against feline calicivirus disease |
| 04/10/2002 | EP1194449A2 Inhibitors of memapsin 2 and use thereof |
| 04/10/2002 | EP1194446A2 Neisseria meningitidis compounds and anti-infection applications thereof |
| 04/10/2002 | EP1194187A1 Antibody-based treatment for streptococcus pneumoniae infection |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP1194172A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194166A2 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 04/10/2002 | EP1194165A1 Tagged epitope protein transposable element |
| 04/10/2002 | EP1194164A1 Prion protein peptides and uses thereof |
| 04/10/2002 | EP1194163A1 Novel methods and medicament for treating infectious diseases involving microbial biofilms |
| 04/10/2002 | EP1194162A1 Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases |
| 04/10/2002 | EP1194157A1 D-form polypeptide which induces immune tolerance and methods of use |
| 04/10/2002 | EP1194152A1 Src kinase inhibitor compounds |
| 04/10/2002 | EP0935458B1 Compositions containing at least one nucleic acid |
| 04/10/2002 | EP0752876B1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 04/10/2002 | EP0607206B1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/10/2002 | CN1344322A BASBO55 polynucleotide and polypeptide from neisseria meningitidis uses thereof |
| 04/10/2002 | CN1344317A 多肽 Polypeptide |
| 04/10/2002 | CN1344276A Antibodies and FV fragment recognizing antigen IORC2 |
| 04/10/2002 | CN1344275A Methods for amyloid removal using anti-amyloid antibodies |
| 04/10/2002 | CN1344170A Methods for inactivating pathogens using broad-spectrum pulsed light |
| 04/10/2002 | CN1344167A Use of antibodies for anticancer vaccination |
| 04/10/2002 | CN1344166A Use of enterobacterium protein ompA associated with antigen for generating antiviral, antiparasitic or antitumoral cytotoxic response |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/09/2002 | US6369211 MAGE-3 peptides presented by HLA class II molecules |
| 04/09/2002 | US6369203 Peptides for the production of preparations for the diagnosis and therapy of systemic lupus |
| 04/09/2002 | US6369201 For increasing muscle synthesis and treating disease in vertebrate subjects, for reducing myostatin activity |
| 04/09/2002 | US6369048 Methods and compositions for inactivating viruses |
| 04/09/2002 | US6369045 Phospholipase A2 inhibitors thereof and use of same in diagnosis and therapy |
| 04/09/2002 | US6368861 Oligonucleotide mediated nucleic acid recombination |
| 04/09/2002 | US6368858 Modulation of multicellular aggregates by pressure from growth in a matrix |
| 04/09/2002 | US6368857 Method for provoking proliferation of cytolytic T cells via the use of decapeptides which complex with HLA-A2 molecules |
| 04/09/2002 | US6368855 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression |
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | US6368852 A peptide capable of inducing cytotoxic t lymphocytes, immune response; anticarcinogenic agents |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368832 A polypeptide of a major capsid protein; diagnosis and therapy for skin cancer; vaccines |
| 04/09/2002 | US6368829 An isolated nucleic acid encoding a polypeptide for a tumor suppressor gene; diagnosis and therapy for diseases |
| 04/09/2002 | US6368790 cDNA encoding P2P proteins and use of P2P cDNA derived antibodies and antisense reagents in determining the proliferative potential of normal, abnormal, and cancer cells in animals and humans |
| 04/09/2002 | US6368640 Method and composition for improving sexual fitness |
| 04/09/2002 | US6368636 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 04/09/2002 | US6368604 Non-pyrogenic derivatives of lipid A |
| 04/09/2002 | US6368603 Immunological composition; mixture of antigens |
| 04/09/2002 | US6368602 Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine |
| 04/09/2002 | US6368601 Isolated dna |
| 04/09/2002 | US6368600 To protect animals from diseases caused by parasitic helminths, such heartworm disease |
| 04/09/2002 | US6368599 Caulobacter LPS immunoadjuvants |
| 04/09/2002 | US6368598 Administering complex of polyamine carrier, drug and connector |
| 04/09/2002 | US6368597 Methods of treating diabetes |
| 04/09/2002 | US6368590 Administering a staphyloccal preparation |
| 04/09/2002 | US6368589 Hybrid gene |
| 04/09/2002 | CA2128407C Synthetic peptides for a rubella vaccine |
| 04/09/2002 | CA1341355C Production and use of il-6 |
| 04/06/2002 | CA2358179A1 Anti-inflammatory vectors |
| 04/04/2002 | WO2002026996A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |